Working… Menu
Trial record 1 of 1 for:    NCT02271711
Previous Study | Return to List | Next Study

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02271711
Recruitment Status : Recruiting
First Posted : October 22, 2014
Last Update Posted : May 23, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 30, 2020
Estimated Study Completion Date : March 30, 2020